Inventor · disambiguated record
Jose Corvalan
Also filed as: CORVALAN JOSE · CORVALAN JOSE R · CORVALAN JOSE RAMON
27 granted patents·10 pending applications·2,892 citations·filing 1999–2020
98Inventor score
Top patents by PatentIndex Score
37 records- 0198US8058418B2Polynucleotides encoding heavy and light chains of antibodies to OPGLBOYLE WILLIAM J·Filed 2007·Granted Nov 15, 2011·40 cites·40 claims
- 0298US7824679B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2007·Granted Nov 2, 2010·87 cites·19 claims
- 0398US7411057B2Nucleic acids encoding human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2005·Granted Aug 12, 2008·87 cites·38 claims
- 0498US7364736B2Antibodies to OPGLAMGEN INC·Filed 2002·Granted Apr 29, 2008·97 cites·25 claims
- 0598US7338660B2Methods of treating cancer and enhancing immune responses with antibodies that bind CD40ABGENIX INC·Filed 2005·Granted Mar 4, 2008·144 cites·73 claims
- 0698US7288251B2Antibodies to CD40PFIZER·Filed 2002·Granted Oct 30, 2007·158 cites·22 claims
- 0798US7132281B2Methods and host cells for producing human monoclonal antibodies to CTLA-4PFIZER·Filed 2004·Granted Nov 7, 2006·220 cites·262 claims
- 0898US7109003B2Methods for expressing and recovering human monoclonal antibodies to CTLA-4PFIZER·Filed 2003·Granted Sep 19, 2006·287 cites·101 claims
- 0998US6682736B1Human monoclonal antibodies to CTLA-4ABGENIX INC·Filed 1999·Granted Jan 27, 2004·776 cites·104 claims
- 1097US8883984B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2013·Granted Nov 11, 2014·38 cites·24 claims
- 1197US8491895B2Methods of treating cancer with human monoclonal antibodies to CTLA-4HANSON DOUGLAS CHARLES·Filed 2012·Granted Jul 23, 2013·99 cites·20 claims
- 1297US8143379B2Human monoclonal antibodies to CTLA-4HANSON DOUGLAS CHARLES·Filed 2007·Granted Mar 27, 2012·121 cites·22 claims
- 1397US7807797B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2007·Granted Oct 5, 2010·76 cites·25 claims
- 1497US7626012B2Nucleic acid molecules which encode antibodies that bind CD40AMGEN FREMONT INC·Filed 2008·Granted Dec 1, 2009·53 cites·21 claims
- 1597US7618633B2Antibodies that bind CD40 and methods of treating cancer and enhancing immune responsesAMGEN FREMONT INC·Filed 2007·Granted Nov 17, 2009·63 cites·45 claims
- 1697US7563442B2Antibodies to CD40 and methods of treating cancer and enhancing immune responsesABGENIX INC·Filed 2005·Granted Jul 21, 2009·62 cites·133 claims
- 1797US7037498B2Antibodies to insulin-like growth factor I receptorPFIZER·Filed 2002·Granted May 2, 2006·252 cites·130 claims
- 1896US8388971B2Antibodies that bind CD40 and methods of treating cancer and enhancing immune responsesBEDIAN VAHE·Filed 2012·Granted Mar 5, 2013·32 cites·20 claims
- 1994US7700742B2Antibodies to insulin-like growth factor I receptorAMGEN FREMONT·Filed 2005·Granted Apr 20, 2010·34 cites·18 claims
- 2094US7422742B2Methods for using human monoclonal antibodies to interleukin-5SCHERING CORP·Filed 2006·Granted Sep 9, 2008·65 cites·6 claims
- 2193US7815907B2Antibodies to insulin-like growth factor I receptorAMGEN FREMONT INC·Filed 2005·Granted Oct 19, 2010·21 cites·97 claims
- 2291US9963508B2Human monoclonal antibodies to CTLA-4AMGEN FREMONT INC·Filed 2014·Granted May 8, 2018·6 cites·13 claims
- 2391US7141653B2Human monoclonal antibodies to interleukin-5ABGENIX INC·Filed 2003·Granted Nov 28, 2006·59 cites·9 claims
- 2490US8409578B2Methods for treating bone loss with antibodies to OPGLBOYLE WILLIAM J·Filed 2011·Granted Apr 2, 2013·4 cites·36 claims
- 2589US7982024B2Antibodies to insulin-like growth factor I receptorAMGEN FREMONT INC·Filed 2010·Granted Jul 19, 2011·11 cites·24 claims
- 2675US2020354464A1Antibodies to opglAMGEN INC·Filed 2020·Application pending·0 cites
- 2772US2020131271A1Antibodies to opglAMGEN INC·Filed 2020·Application pending·0 cites
- 2870US2010098694A1Antibodies to cd40AMGEN FREMONT INC·Filed 2009·Application pending·0 cites
- 2969US2014134157A1Antibodies to opglAMGEN INC·Filed 2013·Application pending·0 cites
- 3068US2017183417A1Antibodies to opglAMGEN INC·Filed 2016·Application pending·0 cites
- 3165US9234041B2Antibodies to insulin-like growth factor I receptorAMGEN FREMONT INC·Filed 2013·Granted Jan 12, 2016·0 cites·20 claims
- 3264US2015266952A1Antibodies to opglAMGEN INC·Filed 2015·Application pending·0 cites
- 3362US2013024956A1Antibodies to cd40PFIZER·Filed 2012·Application pending·0 cites
- 3459US2016152713A1Antibodies to cd40AMGEN FREMONT INC·Filed 2015·Application pending·0 cites
- 3558US2016096894A1Antibodies to insulin-like growth factor i receptorPFIZER·Filed 2015·Application pending·0 cites
- 3654US8642037B2Antibodies to insulin-like growth factor I receptorCOHEN BRUCE D·Filed 2011·Granted Feb 4, 2014·0 cites·16 claims
- 3742US2005058983A1Use of transgenic mice for the efficient isolation of novel human monoclonal antibodies with neutralizing activity against primary HIV-1 strains and novel HIV-1 neutralizing antibodiesFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jose Corvalan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →